Nasdaq
GNLX
Genelux Corporation
- Health Care
- Listed 2023
- 1 day
- +7.6%
- 1 month
- −9.1%
- 1 year
- −24.8%
$2.70 · Mkt cap $121M
At the 6 Aug 2026 close
Nasdaq
Genelux Corporation
$2.70 · Mkt cap $121M
At the 6 Aug 2026 close
Genelux Corporation trades under the ticker GNLX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2023. Its market capitalisation is $121M. The last closing price was $2.70, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −24.8%, and −9.1% over the past month. Returns are price returns and exclude dividends.
This page exists because GNLX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.